Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

Basit Öğe Kaydı
dc.authoridWren, Jonathan D/0000-0003-2776-3545
dc.authoridKaradag, Omer/0000-0002-3443-3117
dc.authoridSaruhan-Direskeneli, Guher/0000-0002-6903-7173
dc.authoriderken, eren/0000-0001-6902-624X
dc.authoridKaradag, Omer/0000-0002-3443-3117
dc.authoridAtes, Askin/0000-0003-1966-3333
dc.authoridTunc, Sevket Ercan/0000-0002-1221-0131
dc.authorwosidWren, Jonathan D/E-5611-2011
dc.authorwosidDireskeneli, Haner/AAS-5508-2020
dc.authorwosidOnen, Fatos/AAA-8970-2021
dc.authorwosidPagnoux, Christian/C-4612-2015
dc.authorwosidSEYAHI, EMIRE/AAB-3576-2020
dc.authorwosidCefle, Ayse/AAT-3653-2020
dc.authorwosidWarrington, Kenneth/CAG-1626-2022
dc.contributor.authorRenauer, Paul A.
dc.contributor.authorSaruhan-Direskeneli, Guher
dc.contributor.authorCoit, Patrick
dc.contributor.authorAdler, Adam
dc.contributor.authorAksu, Kenan
dc.contributor.authorKeser, Gokhan
dc.contributor.authorAlibaz-Oner, Fatma
dc.date.accessioned2024-06-12T11:17:34Z
dc.date.available2024-06-12T11:17:34Z
dc.date.issued2015
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective. Takayasu arteritis is a rare large vessel vasculitis with incompletely understood etiology. This study was undertaken to perform the first unbiased genome-wide association analysis of Takayasu arteritis. Methods. Two independent cohorts of patients with Takayasu arteritis from Turkey and North America were included in our study. The Turkish cohort consisted of 559 patients and 489 controls, and the North American cohort consisted of 134 patients and 1,047 controls of European ancestry. Genotyping was performed using the Omni1-Quad and Omni2.5 genotyping arrays. Genotyping data were subjected to rigorous quality control measures and subsequently analyzed to discover genetic susceptibility loci for Takayasu arteritis. Results. We identified genetic susceptibility loci for Takayasu arteritis with a genome-wide level of significance in IL6 (rs2069837) (odds ratio [OR] 2.07, P = 6.70 x 10(-9)), RPS9/LILRB3 (rs11666543) (OR 1.65, P = 2.34 x 10(-8)), and an intergenic locus on chromosome 21q22 (rs2836878) (OR 1.79, P = 3.62 x 10(-10)). The genetic susceptibility locus in RPS9/LILRB3 lies within the leukocyte receptor complex gene cluster on chromosome 19q13.4, and the disease risk variant in this locus correlates with reduced expression of multiple genes including the inhibitory leukocyte immunoglobulin-like receptor gene LILRB3 (P = 2.29 x 10(-8)). In addition, we identified candidate susceptibility genes with suggestive levels of association (P < 1 x 10(-5)) with Takayasu arteritis, including PCSK5, LILRA3, PPM1G/NRBP1, and PTK2B. Conclusion. Our findings indicate novel genetic susceptibility loci for Takayasu arteritis and uncover potentially important aspects of the pathophysiology of this form of vasculitis.en_US
dc.description.sponsorshipUniversity of Michigan; Vasculitis Foundation; NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [U54-AR-7319, U01-AR5-1874-04]; NIH (National Center for Research Resources) [U54-RR-9497]; NIH (National Center for Advancing Translational Sciences, Office of Rare Diseases Research); NIH [3-P50-CA-093459, 5-P50-CA-097007, 5-R01-ES-011740, 5-R01-CA-133996]; AbbVie; MSD; Pfizer; Hoffmann-La Roche; GlaxoSmithKline; Versus Arthritis [19289] Funding Source: researchfishen_US
dc.description.sponsorshipSupported by the University of Michigan and the Vasculitis Foundation. The Vasculitis Clinical Research Consortium has received support from the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grants U54-AR-7319 and U01-AR5-1874-04, National Center for Research Resources grant U54-RR-9497, and the National Center for Advancing Translational Sciences, Office of Rare Diseases Research). Genotyping data from European American controls were obtained from the High Density SNP Association Analysis of Melanoma: Case-Control and Outcomes Investigation data set (dbGaP study accession: phs000187.v1.p1). Research support for this data set was provided by the NIH (grants 3-P50-CA-093459, 5-P50-CA-097007, 5-R01-ES-011740, and 5-R01-CA-133996).; Dr. Aydin has received consulting fees, speaking fees, and/or honoraria from AbbVie, MSD, and Pfizer (less than $10,000 each). Dr. Pagnoux has received consulting fees, speaking fees, and/or honoraria from Hoffmann-La Roche and GlaxoSmithKline (less than $10,000 each).en_US
dc.identifier.doi10.1002/art.39035
dc.identifier.endpage1368en_US
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.issue5en_US
dc.identifier.pmid25604533en_US
dc.identifier.scopus2-s2.0-84928607870en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1361en_US
dc.identifier.urihttps://doi.org/10.1002/art.39035
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24765
dc.identifier.volume67en_US
dc.identifier.wosWOS:000353775900027en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofArthritis & Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnkylosing-Spondylitisen_US
dc.subjectTurkeyen_US
dc.subjectClassificationen_US
dc.subjectVisualizationen_US
dc.subjectPopulationen_US
dc.subjectDiseaseen_US
dc.titleIdentification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu